Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).

Ishibashi, Yuki; Nakatani, Shimpei; Sotomi, Yohei; Suwannasom, Pannipa; Grundeken, Maik J; Garcia-Garcia, Hector M; Bartorelli, Antonio L; Whitbourn, Robert; Chevalier, Bernard; Abizaid, Alexandre; Ormiston, John A; Rapoza, Richard J; Veldhof, Susan; Onuma, Yoshinobu; Serruys, Patrick W

Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).

Ishibashi, Yuki; Nakatani, Shimpei; Sotomi, Yohei; Suwannasom, Pannipa; Grundeken, Maik J; Garcia-Garcia, Hector M; Bartorelli, Antonio L; Whitbourn, Robert; Chevalier, Bernard; Abizaid, Alexandre; Ormiston, John A; Rapoza, Richard J; Veldhof, Susan; Onuma, Yoshinobu; Serruys, Patrick W.

Afiliación

Ishibashi Y; Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Nakatani S; Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Sotomi Y; Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Suwannasom P; Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands; Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Northern Region Heart Center, Maharaj Nakorn Chiang Mai Hospital, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Grundeken MJ; Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Garcia-Garcia HM; Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Bartorelli AL; Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy.
Whitbourn R; St. Vincent's Hospital, Fitzroy, Victoria, Australia.
Chevalier B; Institut Cardiovasculaire Paris Sud, Massy, France.
Abizaid A; Instituto de Cardiologia Dante Pazzanese, São Paulo, Brazil.
Ormiston JA; Auckland City Hospital, Auckland, New Zealand.
Rapoza RJ; Abbott Vascular, Santa Clara, California.
Veldhof S; Abbott Vascular, Diegem, Belgium.
Onuma Y; Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: yoshinobuonuma@gmail.com.
Serruys PW; International Centre for Cardiovascular Health, Imperial College, London, United Kingdom.

JACC Cardiovasc Interv ; 8(13): 1715-26, 2015 Nov.

Article en En | MEDLINE | ID: mdl-26585622

Asunto(s)

Implantes Absorbibles; Angiografía Coronaria; Enfermedad de la Arteria Coronaria/terapia; Vasos Coronarios/diagnóstico por imagen; Intervención Coronaria Percutánea/instrumentación; Anciano; Enfermedad de la Arteria Coronaria/diagnóstico por imagen; Enfermedad de la Arteria Coronaria/mortalidad; Femenino; Humanos; Estimación de Kaplan-Meier; Modelos Logísticos; Masculino; Persona de Mediana Edad; Análisis Multivariante; Infarto del Miocardio/etiología; Oportunidad Relativa; Intervención Coronaria Percutánea/efectos adversos; Intervención Coronaria Percutánea/mortalidad; Valor Predictivo de las Pruebas; Diseño de Prótesis; Factores de Riesgo; Factores de Tiempo; Resultado del Tratamiento

Palabras clave

bioresorbable scaffold; major adverse cardiac event(s); maximal lumen diameter

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Angiografía Coronaria / Vasos Coronarios / Implantes Absorbibles / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JACC Cardiovasc Interv Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google